Israeli-led research develops molecule that makes immunotherapy available to all cancer patients

Researchers at Tel Aviv University and the University of Lisbon have jointly identified and synthesised a small molecule that could be a more accessible and effective alternative to an antibody that is successfully used to treat a range of cancers. Read more